In focus
Latest feed
ADC Therapeutics Shares Face Brutal Sell-Off After Disappointing Clinical Trial Results
Pharma's Unfolding Drama: 340B Clashes, Vaccine Progress, and Cancer Innovation
The Jemperli Royalty Rumble: GSK's Tesaro Unit Takes AnaptysBio to Court
A New Dawn: Why This Lung Cancer Drug Has Scientists (and Patients) Buzzing
